Why Is Hydroxychloroquine So Hard to Find? [Explained for 2026]

If you have lupus, rheumatoid arthritis, or need hydroxychloroquine for malaria prevention and you've shown up to your pharmacy only to hear "we're out of stock" — you're not alone. Hydroxychloroquine, sold under the brand name Plaquenil, has a complicated availability history that still affects patients today. Understanding why it's sometimes hard to find can help you take the right steps to get your medication without interruption.

What Is Hydroxychloroquine and Who Needs It?

Hydroxychloroquine is a disease-modifying antirheumatic drug (DMARD) and antimalarial medication. It has been FDA-approved since 1955 and is on the World Health Organization's List of Essential Medicines. In 2023, it ranked as the 131st most commonly prescribed medication in the United States, with more than 4 million prescriptions written.

Its primary uses include:

• Systemic lupus erythematosus (SLE) and discoid lupus erythematosus (DLE)
• Rheumatoid arthritis (RA), often as part of combination DMARD therapy
• Malaria prevention and treatment in sensitive regions
• Porphyria cutanea tarda and other off-label autoimmune conditions

For many patients with lupus or RA, hydroxychloroquine is not optional — it is the cornerstone of their treatment. Missing even two weeks of the medication can trigger disease flares and worsen outcomes.

The COVID-19 Shortage: What Happened in 2020

The biggest hydroxychloroquine shortage on record happened in early 2020. When hydroxychloroquine was promoted as a possible COVID-19 treatment, demand surged overnight. The FDA formally recognized the shortage on March 31, 2020, citing "a significant surge in demand." Patients with lupus and rheumatoid arthritis — who depend on hydroxychloroquine for disease control — suddenly found their prescriptions impossible to fill.

Multiple manufacturers reported back orders. Several states, including Nevada, Ohio, Texas, and Idaho, enacted emergency rules requiring pharmacies to confirm a diagnosis before dispensing hydroxychloroquine — limiting 14-day supplies with no refills to slow hoarding. Novartis pledged up to 130 million doses to help ease the crisis.

Research later confirmed that the COVID-19 demand spike did not provide meaningful clinical benefits — and the Emergency Use Authorization for COVID-19 was revoked. But the disruption to patients who genuinely needed the drug for lupus and RA was significant and well-documented.

Is There Still a Hydroxychloroquine Shortage in 2026?

As of 2026, there is no active, nationwide FDA-declared shortage of hydroxychloroquine. The COVID-era shortage was resolved, and the generic version is now manufactured by multiple companies including Dr. Reddy's, Mylan, Amneal, Zydus, and others. Generic supply is generally robust, making hydroxychloroquine one of the more affordable and accessible DMARDs on the market.

That said, patients still sometimes encounter difficulty at individual pharmacies. Here's why:

Why Individual Pharmacies Still Run Out

• Inconsistent ordering patterns: Smaller pharmacies may not stock large quantities of hydroxychloroquine if local demand is low. When a cluster of patients refill at the same time, stock can run out before the next shipment.
• Manufacturer variability: Sandoz has at times had hydroxychloroquine 200 mg (500-count bottles) on back order, while other manufacturers remain available. Your pharmacy may stock only one brand.
• Regional demand spikes: Areas with high lupus or RA populations may see localized stock pressures, especially at the start of a new year when insurance resets and patients refill.
• Supply chain disruptions: Global events, raw material shortages, or manufacturing delays can temporarily reduce supply even when no formal shortage exists.
• Formulary changes: When insurance plans update their drug tiers at the start of a year, patient behavior can change — causing sudden demand shifts at specific pharmacies.

Which Patients Are Most Affected?

Patients who take hydroxychloroquine long-term — particularly those with lupus or RA — are most impacted by availability gaps. Unlike pain medications that can be skipped for a day or two without consequence, stopping hydroxychloroquine abruptly can trigger serious disease flares. Studies have shown that withdrawing hydroxychloroquine in stable lupus patients can exacerbate disease activity and worsen health outcomes.

Pregnant patients and women planning pregnancy who take hydroxychloroquine for lupus face particular urgency: the medication is considered safe and often recommended during pregnancy, so maintaining consistent access is critical.

What Should You Do If Your Pharmacy Is Out of Stock?

Don't panic — and don't just wait. Here are your best options:

1. Call multiple pharmacies. Stock varies widely between chains and independents. CVS, Walgreens, Walmart, Costco, and independent pharmacies may all have different availability.
2. Use medfinder. medfinder calls pharmacies near you to check which ones have hydroxychloroquine in stock, saving you hours of phone tag.
3. Ask about different manufacturers. Your pharmacy may be out of one manufacturer's product but have another in stock. Generic hydroxychloroquine from Dr. Reddy's, Mylan, or Zydus are all therapeutically equivalent.
4. Try mail-order pharmacy. For a maintenance medication taken long-term, a 90-day supply via mail order can provide more consistent access and may cost less with insurance.
5. Contact your prescriber. Your rheumatologist or PCP can sometimes direct your prescription to a pharmacy with confirmed stock, or discuss a short-term bridge medication if needed.

Can You Switch Between Brand and Generic?

Generic hydroxychloroquine sulfate is therapeutically equivalent to brand-name Plaquenil. Most patients can switch between them without issue. However, if you have been stable on one formulation for a long time, discuss any change with your rheumatologist before switching. Some patients with sensitive conditions prefer consistency.

The Bottom Line

Hydroxychloroquine is generally available in 2026 without a formal national shortage. The catastrophic COVID-era disruption has resolved, and generic supply is stable across most manufacturers. However, individual pharmacy stockouts still happen. If you can't find it at your usual pharmacy, acting quickly and checking multiple locations is your best strategy. For more detail on current availability, read our 2026 Hydroxychloroquine Shortage Update.

If you're struggling to locate hydroxychloroquine in stock near you, medfinder can help by calling pharmacies in your area on your behalf.